Constitution Capital
LLY icon

Constitution Capital’s Eli Lilly LLY Stock Holding History

Constitution Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.7M Sell
7,523
-1,418
-16% -$1.67M 4.05% 9
2026
Q2 		$10.7M Buy
8,941
+7,711
+627% +$7.88M 5.51% 3
2026
Q1 		$1.13M Hold
1,230
– – 0.57% 31
2025
Q4 		$1.32M Sell
1,230
-300
-20% -$287K 0.63% 29
2025
Q3 		$1.17M Buy
1,530
+200
+15% +$149K 0.55% 29
2025
Q2 		$1.04M Hold
1,330
– – 0.53% 32
2025
Q1 		$1.1M Buy
1,330
+30
+2% +$25K 0.61% 30
2024
Q4 		$1M Buy
1,300
+20
+2% +$16.6K 0.56% 27
2024
Q3 		$1.13M Sell
1,280
-25
-2% -$22.5K 0.61% 23
2024
Q2 		$1.18M Sell
1,305
-2,050
-61% -$1.64M 0.62% 26
2024
Q1 		$2.61M Buy
3,355
+2,910
+654% +$2.07M 1.47% 15
2023
Q4 		$259K Buy
+445
New +$260K 0.16% 53

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Constitution Capital's LLY Position: Q3 2026 in Review

Constitution Capital reduced its Eli Lilly (LLY) stake by 16% in Q3 2026, selling an estimated $1.67M and leaving 7,523 shares worth $8.7M. The position accounts for 4.05% of the portfolio, ranked #9.

Constitution Capital first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $10.7M in Q2 2026. 2,398 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Constitution Capital held 7,523 shares of Eli Lilly worth $8.7M as of Q3 2026.
  • Constitution Capital sold 1,418 Eli Lilly shares in Q3 2026, an estimated $1.67M.
  • Eli Lilly made up 4.05% of Constitution Capital's portfolio in Q3 2026, its #9 holding.
  • Constitution Capital first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • Constitution Capital's Eli Lilly position peaked at $10.7M in Q2 2026.
  • 2,398 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Constitution Capital's 13F filing for Q3 2026, filed 23 Oct 2026.